U.S. stocks recovered modestly Friday after a sharp selloff linked to rising Treasury yields, but the major indexes still recorded weekly losses. The S&P 500 rose 0.43% Friday and fell 1.4% for the week, while the Nasdaq Composite gained 0.43% on the day and declined 2% for the period, ending three-week winning streaks. The Dow Jones Industrial Average added 517.80 points, or 0.98%, Friday but slipped 0.9% for the week, its second consecutive weekly decline. Financial and materials shares supported Friday’s rebound, healthcare stocks helped the Dow, and crypto-related equities rallied as Bitcoin gained 22% over the week. Longer-dated Treasury yields remained the main market concern amid expectations that higher oil prices could keep inflation elevated. The 10-year yield moved above 4.73% and the 30-year yield reached about 5.27% Friday, pressuring equity valuations. Investors are watching Federal Reserve Chair Kevin Warsh’s speech at next week’s Jackson Hole Economic Policy Symposium for signals on interest rates and central-bank policy. Benzinga’s weekly roundup highlighted bullish developments at Ross Stores, Webull and Berkshire Hathaway, alongside bearish moves involving Moderna, Nvidia and WhiteFiber. Ross Stores reported second-quarter revenue of $6.27 billion, up 13% year over year and above the $6.18 billion estimate, while earnings of $2.66 per share exceeded the $1.94 consensus. Comparable-store sales increased 10%, and the company raised 2026 earnings guidance to $8.61-$8.77 per share from $7.50-$7.74, above the $7.79 analyst estimate. Webull reported second-quarter revenue of $198.83 million, up 51.2% year over year and above the $181.26 million expectation, while adjusted earnings of 5 cents per share beat the 3-cent consensus. Trading-related revenue rose 66% to $147.7 million, funded accounts reached 5.13 million and customer assets climbed to $28.5 billion. Berkshire Hathaway’s second-quarter 13F filing (quarterly report of U.S. equity holdings) showed a new D.R. Horton position and major increases in Alphabet holdings, with the combined position worth about $37.8 billion and ranking as its third-largest. Moderna shares fell as much as 25.69% after a record 176.97% gain in the prior session following positive Phase 3 results for its personalized mRNA cancer vaccine, intismeran autogene. Nvidia faced elevated expectations before its fiscal second-quarter report after shares fell following each of its last three beat-and-raise reports. WhiteFiber declined after proposing a common-stock offering shortly after reporting strong results, raising dilution concerns.